A secondary objective was to assess whether tirzepatide offered superior cardiovascular protection
Because in diabetes care, small hormonal shifts can have large metabolic consequences
Typical follow-up timing is 4 weeks after starting (to assess initial tolerance), then at dose increases, and every 3 months once stable
It provides information about safety, drug levels in breast milk, possible effects on nursing infants, and impacts on milk supply
This master antioxidant works quietly behind the scenes to reduce oxidative damage to brain cells, support healthy neurotransmitter function, and protect against the processes that lead to cognitive decline
The safety of the compounded version of semaglutide may be uncertain, as it is not FDA-approved, and its quality, potency, and consistency may vary depending on the compounding pharmacy, making it essential to consult a healthcare provider before using it